Surgical Intervention for Skin Cancer in Organ Transplant Recipients

  • Henry W. Randle
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

An important complication of solid organ transplantation and chemical immunosuppression is the potential for the development of multiple skin cancers, especially squamous cell carcinomas [1]. The magnitude and severity of these malignancies are troublesome. They are often multiple, are associated with verrucal lesions, are more likely to occur at a younger age, and have a higher recurrence rate than in those who do not receive transplants, are capable of rapid growth, have an aggressive histological growth pattern [2,3], and are prone to metastasis on the trunk and extremities as well as the head and neck.


Squamous Cell Carcinoma Transplant Recipient Sentinel Lymph Node Biopsy Skin Cancer Basal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Randle HW. The historical link between solid-organ transplantation, immunosuppression, and skin cancer. Dermatol Surg 2004; 30(4 pt 2):595–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54:290–300.PubMedCrossRefGoogle Scholar
  3. 3.
    Smith KJ, Hamza S, Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004; 30(4 pt 2):634–41.PubMedCrossRefGoogle Scholar
  4. 4.
    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O’Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61:715–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Shelley WB, Shelley ED. Advanced dermatologic therapy. Philadelphia: Saunders, 1987.Google Scholar
  7. 7.
    Demetrius RW, Randle HW. High-risk nonmelanoma skin cancers. Dermatol Surg 1998; 24:1272–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Euvrard S, Kanitakis J, Claudy A. Neoplastic skin diseases in organ transplant recipients. Am J Cancer 2002; 1:109–20.CrossRefGoogle Scholar
  9. 9.
    Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM, Sengelmann RD, et al.; International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30(4 pt 2):642–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1–17.PubMedCrossRefGoogle Scholar
  11. 11.
    Martinez JC, Otley CC. Megasession: excision of numerous skin cancers in a single session. Dermatol Surg 2005; 31(7 pt 1):757–61.PubMedGoogle Scholar
  12. 12.
    Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992; 26:976–90.PubMedCrossRefGoogle Scholar
  13. 13.
    Carucci JA, Martinez JC, Zeitouni NC, Christenson L, Coldiron B, Zweibel S, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004; 30 (4 pt 2):651–5.PubMedCrossRefGoogle Scholar
  14. 14.
    van Zuuren EJ, Posma AN, Scholtens RE, Vermeer BJ, van der Woude FJ, Bouwes Bavinck JN. Resurfacing the back of the hand as treatment and prevention of multiple skin cancers in kidney transplant recipients. J Am Acad Dermatol 1994; 31 (5 pt 1):760–4.PubMedGoogle Scholar
  15. 15.
    Marks R. Skin cancer in organ transplant patients: from a side effect of social practice to a side effect of medical practice. Dermatol Surg 2004; 30 (4 pt 2):593–4.PubMedCrossRefGoogle Scholar
  16. 16.
    McNamara D. Advised transplant patients of higher skin cancer risk. Skin Allergy News 2005; 36:33.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Henry W. Randle
    • 1
  1. 1.Department of DermatologyMayo Clinic College of MedicineJacksonvilleUSA

Personalised recommendations